NCT00002515View on ClinicalTrials.gov

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1992

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck CancerKidney CancerLiver CancerLymphomaNeuroblastomaOvarian CancerRetinoblastomaSarcomaTesticular Germ Cell Tumor
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

thiotepa

DRUG

topotecan hydrochloride

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

in vitro-treated bone marrow transplantation

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002515 - Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | Biotech Hunter | Biotech Hunter